VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Eli Lilly and Company vs Tyler Technologies, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Eli Lilly and Company
LLY · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Eli Lilly and Company's moat claims, evidence, and risks.
View LLY analysisTyler Technologies, Inc.
TYL · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Tyler Technologies, Inc.'s moat claims, evidence, and risks.
View TYL analysisComparison highlights
- Moat score: both at 66 / 100.
- Segment focus: Eli Lilly and Company has 5 segments (65.5% in Cardiometabolic Health); Tyler Technologies, Inc. has 2 segments (70.7% in Enterprise Software).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: Eli Lilly and Company has 5 moat types across 2 domains; Tyler Technologies, Inc. has 7 across 2.
Primary market context
Eli Lilly and Company
Cardiometabolic Health
Branded cardiometabolic pharmaceuticals (type 2 diabetes, obesity, and related metabolic/cardiovascular conditions; especially incretin therapies)
Global
Patients via prescribers; payers/PBMs; wholesaler & pharmacy channels
Drug developer, manufacturer, and marketer
65.5%
Tyler Technologies, Inc.
Enterprise Software
Public sector enterprise application software for mission-critical back-office functions (ERP/public administration, courts & justice, public safety, education, property & recording)
Primarily United States; also Canada and other international locations
Government agencies and other public entities (state/local/federal), school districts
Vertical software vendor + implementation/services
70.7%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Eli Lilly and Company strengths
Tyler Technologies, Inc. strengths
Segment mix
Eli Lilly and Company segments
Full profile >Cardiometabolic Health
Oligopoly
Oncology
Competitive
Immunology
Competitive
Neuroscience
Competitive
Other
Competitive
Tyler Technologies, Inc. segments
Full profile >Enterprise Software
Competitive
Platform Technologies
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.